A panel of United States health advisers on Tuesday endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the US closer to beginning vaccinations in children ages 5 to 11.
A panel of United States health advisers on Tuesday endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the US closer to beginning vaccinations in children ages 5 to 11.